Pfizer admits defeat on AstraZeneca bid

US pharmaceuticals giant Pfizer has called off its multi-billion pound bid to take over British-Swedish firm AstraZeneca. The decision came after AstraZeneca's board declined an offer worth almost £70bn.

View all 58 updates ›

AstraZeneca shares fall after 'final' Pfizer bid rejected

Shares in AstraZeneca fell 14 per cent upon the market's opening after the company rejected a £55-a-share offer from Pfizer, which the US drug firm described as "final".

More on this story